- Home
- S vs TWST Comparison
S vs TWST Comparison
Compare S & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | S | TWST |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.2B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | S | TWST |
|---|---|---|
| Price | $22.99 | $179.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 31 | 8 |
| Target Price | $19.28 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 8.1M | 1.8M |
| Earning Date | 05-27-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,001,278,000.00 | $376,572,000.00 |
| Revenue This Year | $22.84 | $18.91 |
| Revenue Next Year | $17.32 | $15.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 21.89 | 20.32 |
| 52 Week Low | $11.81 | $23.30 |
| 52 Week High | $24.40 | $186.20 |
Technical Indicators
Market Signals| Indicator | S | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 55.91 | 70.26 |
| Support Level | $12.57 | $41.18 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.16 | 11.17 |
| MACD | 0.09 | 3.45 |
| Stochastic Oscillator | 72.64 | 87.21 |
Price Performance
Historical ComparisonAbout S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.